Apixaban reduces VTE rates compared to enoxaparin in surgery

A study investigating postoperative venous thromboembolism (VTE) prophylaxis in colorectal surgery found that patients receiving apixaban had significantly lower rates of VTE (0.16%) compared to those on enoxaparin (1.29%), with a p-value of 0.023. Despite differences in patient demographics, such as age and operative complexity, the rates of postoperative bleeding were similar between both groups. These findings suggest that apixaban may be a more effective postoperative option for VTE prevention in colorectal surgery patients.